Back to Results
First PageMeta Content



PRESS RELEASE Health Canada Grants Priority Review to AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)  
Add to Reading List

Document Date: 2018-07-18 07:06:17


Open Document

File Size: 322,00 KB

Share Result on Facebook